New Enterprise Associates 14, L.P. Insider Trading $TCON Tracon Pharmaceuticals, Inc.
Get free email notifications about insider trading for New Enterprise Associates 14, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of New Enterprise Associates 14, L.P.. New Enterprise Associates 14, L.P. is 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Casper Sleep Inc. ($CSPR) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in IMARA Inc. ($IMRA) and 10% Owner in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Surface Oncology, Inc. ($SURF).
New Enterprise Associates 14, L.P. in Tracon Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of New Enterprise Associates 14, L.P.: 10% Owner
Holdings: 3,466,003 shares
Current Value: $17,156,715
Latest Transaction: Mar 27 2018
$TCON Market Capitalization: $64.02M
$TCON Previous Close: $4.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of New Enterprise Associates 14, L.P. in Tracon Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, APPN, CSPR, CERC, GRTX, IMRA, LOXO, MRSN, MULE, OYST, SURF, SYBX, TCON
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27 2018 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
| Mar 27 2018 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
| Nov 29 2016 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
| Feb 05 2015 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 5,373,396 | 0 | 0 | |
| Feb 05 2015 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 10.00 | 500,000 | 5,000,000 | 1,888,474 | 1.4 M to 1.9 M (+36.01 %) |
| Feb 05 2015 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 1,388,474 | 0 | 1,388,474 | 0 to 1.4 M |
Page: 1